MedPath

Prospective clinical evaluation of inherited retinal diseases

Not yet recruiting
Conditions
Inherited retinal diseases, Stargardt disease, retinal dystrophyErfelijke netvlies aandoeningen, de ziekte van Stargardt, netvliesdystrofie
Registration Number
NL-OMON20528
Lead Sponsor
Radboud University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Cohort-specific inclusion criteria:

- Clinical diagnosis of STGD and at least two pathogenic or likely pathogenic, therapy-eligible mutations in trans in the ABCA4 gene

Exclusion Criteria

- Mutations in genes that cause autosomal dominant or X-linked retinal dystrophy, or presence of biallelic mutations in autosomal recessive retinal dystrophy genes other than the gene studied in the patient cohort

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Best corrected visual acuity, quantitative fundus autofluorescence intensity data, mean retinal sensitivity as measured by fundus-guided microperimetry, ellipsoid zone area as measured by SD-OCT, visual field sensitivity measured by static perimetry, macular and retinal function using multifocal and full-field ERG amplitudes and implicit time, rod and cone full-field stimulus thresholds.
Secondary Outcome Measures
NameTimeMethod
Quality of life and patient reported outcomes
© Copyright 2025. All Rights Reserved by MedPath